SCHEMBL7018372

SCHEMBL7018372

O=C(O)c1cccnc1C#Cc1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 2/20 0.53
KDM4E B2RXH2 2/20 0.52
TDP1 Q9NUW8 1/20 0.52
ALDH1A1 P00352 5/20 0.50
ALOX15 P16050 2/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 1/20 0.50
BLM P54132 1/20 0.50
AGER Q15109 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HNF4A P41235 1/20 0.47
DHODH Q02127 1/20 0.46
MYC P01106 1/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
AKR1C2 P52895 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14658899 0.87 FFAR1 (0.43) NAPRTKDM4ETDP1ALDH1A1ALOX15
SCHEMBL833521 0.87 NPC1 (0.58) NAPRTKDM4ETDP1ALDH1A1ALOX15
SCHEMBL28358322 0.79 HTT (0.53) ALDH1A1MAPTTSHRL3MBTL1LMNA
SCHEMBL8833877 0.78 KDM4E (0.59) NAPRTKDM4ETDP1ALDH1A1ALOX15
Benzene SCHEMBL7527131 0.77 KDM4E (0.57) NAPRTKDM4ETDP1ALDH1A1ALOX15
SCHEMBL1663588 0.77 KDM4E (0.57) NAPRTKDM4ETDP1ALDH1A1ALOX15
SCHEMBL28950071 0.77 APP (0.46) KDM4EALDH1A1MAPTTSHRL3MBTL1
SCHEMBL8182627 0.77 KDM4E (0.57) NAPRTKDM4ETDP1ALDH1A1ALOX15
SCHEMBL10402120 0.75 KDM4E (0.55) NAPRTKDM4ETDP1ALDH1A1ALOX15
SCHEMBL23320310 0.73 KDM4E (0.45) NAPRTKDM4ETDP1ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296972-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS Aventis Pharmaceuticals Inc. (US) 2003-04-02 EP disclosed
WO-2001090101-A1 ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRYPTASE INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2001-11-29 WO disclosed